Eagle Pharmaceuticals, Inc. (EGRX)
NASDAQ: EGRX · IEX Real-Time Price · USD
4.160
-0.080 (-1.89%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Eagle Pharmaceuticals Market Cap
Eagle Pharmaceuticals has a market cap or net worth of $54.03 million as of April 26, 2024. Its market cap has decreased by -85.46% in one year.
Market Cap
54.03M
Enterprise Value
108.86M
1-Year Change
-85.46%
Ranking
Category
Stock Price
$4.16
Market Cap Chart
Since February 12, 2014, Eagle Pharmaceuticals's market cap has decreased from $178.40M to $54.03M, a decrease of -69.72%. That is a compound annual growth rate of -11.05%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 55.10M | -6.77% |
Apr 24, 2024 | 59.10M | -4.52% |
Apr 23, 2024 | 61.90M | 4.74% |
Apr 22, 2024 | 59.10M | -1.34% |
Apr 19, 2024 | 59.90M | 2.92% |
Apr 18, 2024 | 58.20M | 2.11% |
Apr 17, 2024 | 57.00M | -6.40% |
Apr 16, 2024 | 60.90M | -9.78% |
Apr 15, 2024 | 67.50M | 13.26% |
Apr 12, 2024 | 59.60M | -3.72% |
Apr 11, 2024 | 61.90M | 1.48% |
Apr 10, 2024 | 61.00M | -5.13% |
Apr 9, 2024 | 64.30M | -0.92% |
Apr 8, 2024 | 64.90M | -2.41% |
Apr 5, 2024 | 66.50M | -1.77% |
Apr 4, 2024 | 67.70M | 7.29% |
Apr 3, 2024 | 63.10M | 8.05% |
Apr 2, 2024 | 58.40M | -5.65% |
Apr 1, 2024 | 61.90M | -9.10% |
Mar 28, 2024 | 68.10M | 4.61% |
Mar 27, 2024 | 65.10M | -0.61% |
Mar 26, 2024 | 65.50M | -0.76% |
Mar 25, 2024 | 66.00M | 0.61% |
Mar 22, 2024 | 65.60M | -3.39% |
Mar 21, 2024 | 67.90M | -7.99% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Ikena Oncology | 65.15M |
Moolec Science | 64.99M |
Theratechnologies | 63.45M |
Cryo-Cell International | 62.57M |
Lantern Pharma | 61.98M |
Mural Oncology | 61.94M |
CollPlant Biotechnologies | 61.85M |
vTv Therapeutics | 60.76M |